HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of early treatment of prostate cancer with the 5alpha-reductase inhibitor turosteride in Dunning R3327 prostatic carcinoma in rats.

AbstractBACKGROUND:
Turosteride, a selective 5alpha-reductase inhibitor, was reported to be effective in inhibiting the growth of established tumors in the Dunning R3327 rat prostatic carcinoma model. We evaluated the preventive effect of turosteride when administered during the latency period in this prostatic tumor model.
METHODS:
Turosteride was given orally, 6 days a week for 10-15 weeks, starting at different times: 1) 5 weeks after tumor implantation, when tumors were not yet palpable, or 2) 1 day after tumor implantation. In each experiment, one group of animals was castrated on the first treatment day.
RESULTS:
When treatment started 5 weeks after tumor implantation, neither turosteride (at 50 and 200 mg/kg/day) nor castration reduced tumor incidence (91-100%). Tumor growth was reduced in groups treated with the highest dose of turosteride and in castrated rats. When treatment started 1 day after tumor implantation, castration resulted in a 62% tumor incidence compared to 100% in controls, while turosteride at 200 mg/kg/day was not effective in reducing tumor incidence. However, as in the previous experiment, the compound was highly effective in reducing tumor growth.
CONCLUSIONS:
The antitumor activity profile of turosteride seems not to be related to the timing of treatment. Given either 5 weeks or 1 day after tumor implantation, the compound did not reduce tumor take, while it maintained effective tumor growth-inhibiting activity in both cases.
AuthorsT Zaccheo, D Giudici, E di Salle
JournalThe Prostate (Prostate) Vol. 35 Issue 4 Pg. 237-42 (Jun 01 1998) ISSN: 0270-4137 [Print] United States
PMID9609545 (Publication Type: Journal Article)
Chemical References
  • 5-alpha Reductase Inhibitors
  • Enzyme Inhibitors
  • Finasteride
  • turosteride
Topics
  • 5-alpha Reductase Inhibitors
  • Administration, Oral
  • Animals
  • Cell Line
  • Drug Administration Schedule
  • Enzyme Inhibitors (administration & dosage, therapeutic use)
  • Finasteride (administration & dosage, analogs & derivatives, therapeutic use)
  • Male
  • Orchiectomy
  • Organ Size (drug effects)
  • Prostate (anatomy & histology, drug effects, pathology)
  • Prostatic Neoplasms (drug therapy, pathology)
  • Rats
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: